Literature DB >> 2909542

Dual mechanisms of platelet hormone receptor desensitization. Differential importance between agonists of protein kinase C-dependent and -independent pathways.

M F Crouch1, E G Lapetina.   

Abstract

Several different agonists, among them alpha-thrombin, platelet-activating factor, vasopressin, thromboxane A2, and endoperoxides, activate platelets to aggregate and secrete granular contents. Each of these agents is thought to act by inducing the turnover of inositol phospholipids and generating the second messenger molecules inositol 1,4,5-trisphosphate and 1,2-diacylglycerol. However, within minutes, the action of these agonists desensitizes. We have studied the characteristics of this desensitization process for the agonists mentioned above in an attempt to clarify the mechanisms involved. Our results show that two different pathways of desensitization exist, one that is mediated by protein kinase C and another that is independent of this enzyme. In addition, the contribution of these pathways to desensitization differs for the agonists studied. Our data suggest that partial agonists and strong agonists differ in the rate at which the primary response is desensitized rather than in their ability to couple to phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909542

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Homologous desensitization of ATP-mediated elevations in cytoplasmic calcium and prostacyclin release in human endothelial cells does not involve protein kinase C.

Authors:  T D Carter; J S Newton; R Jacob; J D Pearson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

2.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  BW755C or staurosporine inhibits collagen-stimulated phosphoinositide phosphorylation in platelets.

Authors:  L M Thomas; B J Holub
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

4.  Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.

Authors:  W R Bishop; J August; J M Petrin; J K Pai
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

5.  Studies on fenestral contraction in rat liver endothelial cells in culture.

Authors:  Z Gatmaitan; L Varticovski; L Ling; R Mikkelsen; A M Steffan; I M Arias
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Regulation of the receptor for platelet-activating factor on human platelets.

Authors:  J A Burgers; J W Akkerman
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

7.  Acute reduction of TxA2 platelet binding sites after in vivo administration of a TxA2 receptor inhibitor.

Authors:  P A Modesti; A Colella; I Cecioni; G F Gensini; R Abbate; G G Neri Serneri
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

8.  Ca2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathways.

Authors:  C P Thomas; M J Dunn; R Mattera
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

9.  Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction.

Authors:  P Roevens; D de Chaffoy de Courcelles
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

10.  Influence of phorbol esters, and diacylglycerol kinase and lipase inhibitors on noradrenaline release and phosphoinositide hydrolysis in chromaffin cells.

Authors:  J A Jones; P J Owen; M R Boarder
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.